BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20449693)

  • 1. Intussusception incidentally detected by FDG-PET/CT in a pediatric lymphoma patient.
    Chamroonrat W; Cheng G; Servaes S; Zhuang H
    Ann Nucl Med; 2010 Aug; 24(7):555-8. PubMed ID: 20449693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT detection of intussusception caused by lymphoma in a pediatric patient.
    Kang HJ; Beylergil V; Price AP; Abramson SJ; Carrasquillo JA
    Clin Nucl Med; 2014 Jan; 39(1):97-8. PubMed ID: 24300360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intussusception caused by an ileocecal lymphoma disclosed on 18F-FDG-PET/CT.
    Ha-Kawa S; Ueno Y
    Intern Med; 2013; 52(7):827-8. PubMed ID: 23545685
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental detection of pseudodiverticulum of sigmoid colon on (18)F-FDG-PET/CT in a patient with lymphoma.
    Karuppuswamy Kamaleshwaran K; Chakraborty D; Kashyap R; Bhattacharya A; Singh B; Mittal BR
    Hell J Nucl Med; 2010; 13(2):171-2. PubMed ID: 20808994
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental detection of unsuspected pulmonary embolism on oncologic FDG PET/CT imaging.
    Khandelwal AR; Li G; Takalkar AM
    Clin Nucl Med; 2011 Aug; 36(8):720-2. PubMed ID: 21716032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG PET/CT findings in two patients with pyothorax-associated lymphoma.
    Ito K; Kubota K; Morooka M; Aruga T; Mochizuki N; Itami J; Matsuda H
    Clin Nucl Med; 2010 Oct; 35(10):802-5. PubMed ID: 20838292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG PET/CT in primary tonsillar lymphoma.
    Zhang MJ; Jiang JJ; Jiang MS; He W
    Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
    Allen-Auerbach M; de Vos S; Czernin J
    Radiol Clin North Am; 2008 Mar; 46(2):199-211, vii. PubMed ID: 18619376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT imaging suggests lymphoma involving prostate may be more resistant to treatment.
    Li G; Dhawan M; Takalkar AM; Lilien DL
    Clin Nucl Med; 2011 Mar; 36(3):255-7. PubMed ID: 21285695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive transformation of germinal centers in a pediatric patient: initial evaluation and follow-up with serial F-18 FDG PET/CT imaging.
    Makis W; Ciarallo A; Novales-Diaz JA; Lisbona R
    Clin Nucl Med; 2011 Oct; 36(10):e139-41. PubMed ID: 21892026
    [No Abstract]   [Full Text] [Related]  

  • 12. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
    Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
    Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
    Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
    Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
    Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
    Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
    Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J
    Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a pediatric patient.
    Liu B; Lee NJ; Otero HJ; Servaes S; Zhuang H
    Clin Nucl Med; 2014 Feb; 39(2):206-8. PubMed ID: 24152660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of 18F-fluorodeoxyglucose coincidence gamma camera tomography with gallium scanning for the staging of lymphoma.
    Lin P; Chu J; Kneebone A; Moylan E; Jalaludin B; Pocock N; Kiat H; Rosenfeld D
    Intern Med J; 2005 Feb; 35(2):91-6. PubMed ID: 15705137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.